cholangitis
cholangitis
Explore linked clinical trials. Standard reference: MONDO:000478957 results · Page 1 of 3
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Investigation of Vancomycin Efficacy in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis | Cholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Recruiting | Phase 2 | 2026-10-09 | NCT07341282 | |
| Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND) | Cholangitis, Sclerosing, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Abnormalities, Digestive System Diseases, Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, bile duct disorder, biliary atresia, biliary tract disorder, cholangitis, skin disorder | Active, not recruiting | Phase 3 | 2026-10-06 | NCT06553768 | |
| A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis | Cholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, primary sclerosing cholangitis | Recruiting | Phase 3 | 2026-10-01 | NCT07387549 | |
| A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis. | Cholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, primary sclerosing cholangitis | Active, not recruiting | Phase 2 | 2026-10-01 | NCT05627362 | |
| Nemolizumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus | Cholangitis, Sclerosing, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholangitis, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitis, primary sclerosing cholangitis | Not yet recruiting | Phase 2 | 2026-09-28 | NCT07843420 | |
| FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis | Cholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, primary sclerosing cholangitis | Recruiting | Phase 2 | 2026-09-24 | NCT06286709 | |
| Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach | Cholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, liver disorder, primary sclerosing cholangitis | Recruiting | Not stated | 2026-09-22 | NCT04685200 | |
| Vancomycin Efficacy in Response to Dysbiosis in Atypical Colitis | Cholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Not yet recruiting | Phase 2 | 2026-09-10 | NCT07646223 | |
| Endoscopic Radiofrequency Ablation for Unresectable Cholangiocarcinoma | Biliary Tract Neoplasms, Bites and Stings, Chemically-Induced Disorders, Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, bile duct cancer, bile duct disorder, bile duct neoplasm, biliary tract disorder, carcinoma, cholangiocarcinoma, cholangitis, epithelial neoplasm, hilar cholangiocarcinoma, injury, liver cancer, liver disorder, neoplasm, poisoning | Recruiting | Not applicable | 2026-09-09 | NCT06175845 | |
| A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC) | Cholangitis, Sclerosing, Digestive System Diseases, Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, bile duct disorder, biliary tract disorder, cholangitis, cholestasis, primary sclerosing cholangitis, skin disorder | Active, not recruiting | Phase 2 | 2026-08-26 | NCT04663308 | |
| A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, bile duct disorder, biliary tract disorder, cholangitis, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitis, skin disorder | Active, not recruiting | Phase 2 | 2026-08-25 | NCT05050136 | |
| A-LiNK: Improving Outcomes in Autoimmune Liver Disease | Cholangitis, Sclerosing, Digestive System Diseases, Hepatic Insufficiency, Hepatitis, Chronic, autoimmune disease, autoimmune hepatitis, bile duct disorder, biliary tract disorder, cholangitis, chronic liver failure, hepatitis, immune system disorder, liver disorder, liver failure, primary sclerosing cholangitis | Recruiting | Not stated | 2026-08-19 | NCT05750498 | |
| MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease | Cholangitis, Sclerosing, Digestive System Diseases, Hepatitis, Chronic, autoimmune disease, autoimmune hepatitis, bile duct disorder, biliary tract disorder, cholangitis, hepatitis, immune system disorder, liver disorder, primary sclerosing cholangitis | Recruiting | Not stated | 2026-08-19 | NCT03178630 | |
| MRI Based Biomarkers in Pediatric Autoimmune Liver Disease | Cholangitis, Sclerosing, Digestive System Diseases, Hepatitis, Chronic, autoimmune disease, autoimmune hepatitis, bile duct disorder, biliary tract disorder, cholangitis, hepatitis, immune system disorder, liver disorder, primary sclerosing cholangitis | Recruiting | Not stated | 2026-08-19 | NCT03175471 | |
| LEOPARD Prospective Validation Cohort 1 | Cholangitis, Sclerosing, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholangitis, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitis, primary sclerosing cholangitis | Recruiting | Not stated | 2026-07-29 | NCT06723275 | |
| LEOPARD Training and Validation Data Collection Study | Cholangitis, Sclerosing, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholangitis, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitis, primary sclerosing cholangitis | Recruiting | Not stated | 2026-07-29 | NCT06675604 | |
| Detoxification of the Liver In PSC (Dolphin) | Cholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, primary sclerosing cholangitis | Recruiting | Phase 2 | 2026-07-21 | NCT05835505 | |
| Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation | Cholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, primary sclerosing cholangitis | Recruiting | Phase 2 | 2026-07-17 | NCT06905054 | |
| Primary Sclerosing Cholangitis in Children | Cholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, liver disorder, primary sclerosing cholangitis | Recruiting | Not stated | 2026-07-14 | NCT04181138 | |
| The Safety and Efficacy of Upadacitinib in Refractory Autoimmune Related Cholangitis and Atopic Dermatitis With Moderate to Severe Itching | Cholangitis, Sclerosing, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Fibrosis, Hypersensitivity, Immediate, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Diseases, Eczematous, Skin Manifestations, Skin and Connective Tissue Diseases, atopic eczema, bile duct disorder, biliary tract disorder, cholangitis, cholestasis, cirrhosis of liver, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, intrahepatic cholestasis, liver disorder, primary biliary cholangitis, skin disorder | Not yet recruiting | Phase 2 | 2026-07-01 | NCT07678645 | |
| EUS-Guided Gallbladder Drainage Versus Conservative Management in Patients Unfit for Surgery After a Biliary Event Without Cholecystitis. DRECON Study | Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, choledocholithiasis, cholelithiasis, common bile duct disorder | Not yet recruiting | Not applicable | 2026-06-22 | NCT07655778 | |
| Prospective Cohort of Immune Checkpoint Inhibitor-induced Hepatitis | Chemically-Induced Disorders, Digestive System Diseases, Drug-Related Side Effects and Adverse Reactions, bile duct disorder, biliary tract disorder, cholangitis, drug-induced liver injury, hepatitis, liver disorder, poisoning | Recruiting | Not stated | 2026-06-18 | NCT06864481 | |
| Sedation Methods in Percutaneous Transhepatic Biliary Drainage: Procedure Quality and Recovery | Digestive System Diseases, bile duct disorder, biliary tract disorder, cancer, cholangitis, neoplasm | Recruiting | Not applicable | 2026-06-10 | NCT07640243 | |
| Biodegradable Stents in Primary Sclerosing Cholangitis | Cholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis | Recruiting | Not applicable | 2026-05-29 | NCT07607353 | |
| Evaluation of an Oral Microbiota-based Therapeutic as a Treatment Option for PSC | Cholangitis, Sclerosing, Digestive System Diseases, bile duct disorder, biliary tract disorder, cholangitis, primary sclerosing cholangitis | Recruiting | Early phase 1 | 2026-05-20 | NCT06197308 |